Posted on:
When we think of the impact of a spinal cord injury, we tend to focus on the significant limitations with the loss of mobility, but for a large share of people living with this injury, it’s actually the chronic pain which is one of the most challenging issues to manage long-term. Neuropathic pain affects about…
Posted on:
Researchers from the Kolling Institute and the University of Sydney have joined with international collaborators from Spain, America, South Korea and Brazil to develop a website to improve the genetic diagnosis and management of Menière disease. The Menière Disease Atlas of Genes and Cells is a free, open resource which can be used by researchers…
Posted on:
We would like to congratulate one of our emerging leaders at the Kolling Institute who has received a prestigious award at an international conference in Melbourne. In her final year of her PhD, Caitlin Fenech has been presented with a President’s Special Commendation award at the 36th World Congress of Neuropsychopharmacology, CINP-AsCNP 2025. Caitlin has…
Posted on:
An innovative tool which could revolutionise the detection and treatment of musculoskeletal and neurological conditions will be further developed following a $230,000 gift. The donation was made following a campaign by the University of Sydney’s Advancement team and the NORTH Foundation to support the world’s first open-source dataset of whole-body muscle composition. The Kolling Institute’s…
Posted on:
More than 80 top national and international scientists converged on the Kolling Institute for the 4th Optogenetics Australia meeting, featuring the very latest light technologies driving research. The event attracted dynamic keynote speakers from the USA, Europe and China, and leading research institutions across Australia. Chair of Optogenetics Australia and senior Kolling Institute pain medicine…
Posted on:
In a crucial step towards a better understanding of Meniere’s disease, researchers at the Kolling Institute and the University of Sydney have discovered a gene mutation which could greatly inform future treatment of the disease. Meniere’s is a rare inner ear disease associated with sensorineural hearing loss, vertigo and debilitating tinnitus. There is currently no…
Posted on:
For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has…
Posted on:
Internationally respected clinical academic Professor Paul Glare has been named a Member of the Order of Australia for his significant service to medicine in the fields of pain management and palliative care. Professor Glare is a specialist physician in pain medicine and senior researcher with the Kolling Institute. He is the Director of the Michael…
Posted on:
Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is…
Posted on:
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports…
Copyright © 2026 Kolling Institute
All rights reserved